These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 17902)

  • 1. [Exchange sodium and angiotensin II in the blood in essential arterial hypertension].
    Deutsch G; Cristodorescu R; Gavrilescu S; Berger E; Drugărin D
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1977; 29(2):113-9. PubMed ID: 17902
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: Angiotensin blockade: new pharmacologic tools for understanding and treating hypertension.
    Laragh JH
    N Engl J Med; 1975 Mar; 292(13):695-6. PubMed ID: 235091
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of arterial hypertension in the aged].
    Puras A; Alcázar JM; Miranda B; Oliet A; Rodicio JL; Ruilope LM
    Med Clin (Barc); 1989 Feb; 92(7):245-9. PubMed ID: 2716405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dietary sodium on angiotensin-converting enzyme (ACE) inhibition and the acute hypotensive effect of enalapril (MK-421) in essential hypertension.
    Jackson B; Cubela R; Johnston CI
    J Hypertens; 1984 Aug; 2(4):371-7. PubMed ID: 6099390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin-sodium profile and its therapeutical implications in arterial hypertension.
    Cristodorescu R; Deutsch G; Mihalaş I
    Med Interne; 1978; 16(2):157-68. PubMed ID: 678343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum uric acid in mild essential hypertension.
    Barsotti G; Mezzomo N; Cristofano C; Giovannetti S
    Clin Nephrol; 1983 Sep; 20(3):145-8. PubMed ID: 6627763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma renin and angiotensin levels in experimental hypertension in the rat.
    Hutchinson JS; Matthews PG; Dax E; Johnston CI
    Clin Exp Pharmacol Physiol; 1975; Suppl 2():83-8. PubMed ID: 1183094
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal abnormalities in nonmodulating essential hypertension.
    Williams GH; Moore TJ; Hollenberg NK
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):39-44. PubMed ID: 3037888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin-angiotensin system in mild essential hypertension. The functional significance of angiotensin II in untreated and thiazide-treated hypertensive patients.
    Ibsen H; Leth A; Hollnagel H; Kappelgaard AM; Nielsen MD; Christensen NJ; Giese J
    Acta Med Scand; 1979; 205(7):547-55. PubMed ID: 474180
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolism and blood levels of angiotensin II in normal subjects, renal disease, and essential hypertension.
    Catt KJ; Cain MD; Coghlan JP; Zimmet PZ; Cran E; Best JB
    Circ Res; 1970 Oct; 27():Suppl 2:177+. PubMed ID: 4319094
    [No Abstract]   [Full Text] [Related]  

  • 11. [Nutrition and arterial hypertension].
    Galassi A; Mangiameli S
    Boll Soc Ital Cardiol; 1979; 24(2):197-202. PubMed ID: 548095
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of the renin-angiotensin system in the regulation of aldosterone biosynthesis and arterial pressure during sodium deficiency.
    McCaa RE
    Circ Res; 1977 May; 40(5 Suppl 1):I157-62. PubMed ID: 870226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension: selection of treatment in relation to the mechanisms raising blood pressure.
    Conway J
    Brux Med; 1973 Nov; Spec No(0):87-98. PubMed ID: 4371910
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of a therapeutic scheme in essential arterial hypertension. I. Initial control and conditioning factors].
    Ruilope L; Alcazar JM; Morales JM; Barrientos A; Alvarez-Ude F; Bello I; Rodicio JL
    Rev Clin Esp; 1978 Dec; 151(5):367-70. PubMed ID: 741020
    [No Abstract]   [Full Text] [Related]  

  • 15. [Reinstatement of sodium restriction and diuretics in the treatment of hypertension].
    Dorhout Mees EJ
    Ned Tijdschr Geneeskd; 1996 Dec; 140(52):2610-4. PubMed ID: 9026738
    [No Abstract]   [Full Text] [Related]  

  • 16. [Essential hypertension: biochemical analysis--selective treatment].
    Bühler R; Laragh JH
    Schweiz Rundsch Med Prax; 1973 Apr; 62(16):489-91. PubMed ID: 4349069
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
    Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
    Prog Biochem Pharmacol; 1976; 12():230-41. PubMed ID: 1019166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moderate sodium restriction and various diuretics in the treatment of hypertension.
    Ram CV; Garrett BN; Kaplan NM
    Arch Intern Med; 1981 Jul; 141(8):1015-9. PubMed ID: 7247587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of renin and angiotensin in hypertension.
    Brown JJ; Fraser R; Leckie B; Lever AF; Morton JJ; Padfield PL; Semple PF; Robertson JI
    Cardiovasc Clin; 1978; 9(1):55-89. PubMed ID: 352522
    [No Abstract]   [Full Text] [Related]  

  • 20. [Various aspects of the action of angiotensin II in essential arterial hypertension].
    Moga A; Uza G
    Stud Cercet Med Interna; 1967; 8(3):211-20. PubMed ID: 4294608
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.